PerkinElmer to Acquire Oxford Immunotec Global | Clinical Lab Products
PerkinElmer to acquire diagnostics company Oxford Immunotec for $591m
KOL Spotlight Interview with Dr. Ruth Brignall - EUROIMMUN BLOG
Oxford Immunotec North America | Oxford Immunotec is a leading global diagnostics company with an 18-year history of transforming T cell science into meaningful insights.
We're excited to announce that PerkinElmer has reached an agreement to acquire Oxford Immunotec, headquartered near Oxford, UK. This… | Instagram
PerkinElmer's Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select To Automate Clinically Superior Tuberculosis Detection | Technology Networks
PerkinElmer to acquire Oxford Immunotec for $591M
Convenzis - Our Clients
PerkinElmer Completes Acquisition of Oxford Immunotec
PerkinElmer Completes Acquisition of Oxford Immunotec Global PLC | Technology Networks
T-SPOT.TB now from Revvity | Same test. More potential.
Perkinelmer to acquire Oxford Immunotec for $591M | 2021-01-07 | BioWorld
LQA 300 FT-IR Wine Analyzer | PerkinElmer
PerkinElmer To Buy UK-Based Immunodiagnostics For $155M :: Medtech Insight
PerkinElmer Completes Acquisition of Oxford Immunotec Global PLC
Oxford Immunotec - Crunchbase Company Profile & Funding
Oxford Immunotec to be acquired for $591M by Waltham company | Worcester Business Journal
Covington Represents Oxford Immunotec in its 591M Acquisition by PerkinElmer | Covington & Burling LLP
PerkinElmer acquires Oxford Immunotec to expand its TB test portfolio
DiaSorin interessante anche oltre i test Covid, per Akros è da accumulare - MilanoFinanza News
PerkinElmer buying UK diagnostics firm for $591 million - The Boston Globe
Expert Series with Dr. Ali Hassoun – Oxford Immunotec Medical Education